Teva Pharmaceutical Industries Ltd (TEVJF) Shares Outstanding (2009 - 2026)

Teva Pharmaceutical Industries (TEVJF) has 18 years of Shares Outstanding (Entity) data on file, last reported at $1.3 billion in Q2 2026.

• Quarterly Shares Outstanding (Entity) rose 1.44% year-over-year to $1.3 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.3 billion (up 1.44% YoY) and the FY2025 annual result came in at $1.3 billion, up 1.37% from the prior year.
• Shares Outstanding (Entity) was little changed at $1.3 billion in Q2 2026, from $1.3 billion in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $1.3 billion in Q1 2026 to a low of $1.1 billion in Q2 2022.
• A 5-year average of $1.2 billion and a median of $1.2 billion in 2024 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) dropped 8.19% — and 2023, when it increased 10.54%.
• Tracing TEVJF's Shares Outstanding (Entity) over 5 years: stood at $1.2 billion in 2022, then advanced by 0.82% to $1.2 billion in 2023, then increased by 1.06% to $1.2 billion in 2024, then rose by 1.37% to $1.3 billion in 2025, then advanced by 1.11% to $1.3 billion in 2026.
• The last three Shares Outstanding (Entity) figures came in at $1.3 billion (Q2 2026), $1.3 billion (Q1 2026), and $1.3 billion (Q4 2025), per Business Quant data.